Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Date:10/30/2008

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's ability and efforts to navigate the economic environment; the prioritization of the lorcaserin program; the redemption of the Series B Convertible Preferred Stock in cash; future results of clinical trials; advancement of Arena's pipeline; therapeutic indication, tolerability, side effects, efficacy and potential of Arena's or its collaborators' product candidates and compounds; financial guidance; and other statements about Arena's focus, strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking sta
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
2. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
3. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
4. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
6. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
9. Arena Pharmaceuticals Announces Public Offering of Common Stock
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Raleigh, NC (PRWEB) March 02, 2015 ... response can be a better predictor of outcomes for ... here to read details of the new study ... and pathologists at the University of Eastern Piedmont followed ... underwent talc pleurodesis treatment for excess lung fluid. ...
(Date:3/2/2015)... 2015 Gummy smile reduction expert, ... reshaping can involve one or several procedures to reduce the ... tissue for a more even gum line. Dr. Farnoosh is ... that can permanently lighten discolored or naturally dark gums. ... involves a personalized treatment plan to address a patient’s specific ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Creative Recovery at Recovery Unplugged™—will be delivering a ... A Singer/Songwriter's Perspective on the Art of Healing ... Addiction Disorders (NCAD) and Behavioral Healthcare Executive Summit ... his name, Mr. Supa’s songs have been recorded ...
(Date:3/2/2015)... 2015 Over the last five years ... vendors seeking to expand their geographic presence and achieve ... to reach $6.2 billion by 2019 at CAGR of ... the U.S. and Canada and a major part of ... regions such as Asia-Pacific including China and India, Latin ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... N.J., June 16 MedeFile,International, Inc. (OTC ... electronic medical records management solutions, today announced,that ... firm offering group,and individual health insurance to ... System to both its existing business,clients and ...
... by FTVentures Will Expand Product Line and International ... ... 16 PSS Systems, the leader,in legal holds and retention management ... The company,s existing,investors, including Lightspeed Venture Partners, Azure Capital, Granite,Ventures, and ...
... Cancer Alliance-Georgia Advocates Acknowledged with Resolution, WASHINGTON, ... Georgia State Senators John Wiles (R-37th), Chip,Rogers (R-21st), ... (D-6th) for introducing Georgia Senate Resolution 1215 (S.R. ... the end of the 2008 legislative session,S.R. 1215 ...
... the brew could boost heart health, study finds , , MONDAY, ... Drinking up to six cups a day of caffeinated or ... study shows. , In fact, coffee might even help the ... suggest that long-term, regular coffee consumption does not increase the ...
... 16 The American,Association for Homecare (AAHomecare) applauded ... that will delay for at least 18 months ... home,medical equipment and services. The bill, H.R. 6252, ... of 2008.", The competitive acquisition or "competitive ...
... Hain Celestial,Group, Inc. (Nasdaq: HAIN ), a leading ... announced that Irwin D. Simon, President and,Chief Executive Officer, ... June 18th at 9:30 AM., (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/NYTH131 ... Hain Celestial Group started to,Change the Way the World ...
Cached Medicine News:Health News:The Benefit Source, Inc. to Market MedeFile Electronic Medical Records Management Solution to National Customer Base 2Health News:The Benefit Source, Inc. to Market MedeFile Electronic Medical Records Management Solution to National Customer Base 3Health News:The Benefit Source, Inc. to Market MedeFile Electronic Medical Records Management Solution to National Customer Base 4Health News:PSS Systems Secures $18 Million in Financing 2Health News:PSS Systems Secures $18 Million in Financing 3Health News:PSS Systems Secures $18 Million in Financing 4Health News:Lung Cancer Alliance Praises State Senate Action in Georgia 2Health News:Coffee Drinkers Might Live Longer 2Health News:Coffee Drinkers Might Live Longer 3Health News:American Association for Homecare Applauds Bill to Delay the Flawed Medicare Bidding Program for Home Medical Equipment 2Health News:American Association for Homecare Applauds Bill to Delay the Flawed Medicare Bidding Program for Home Medical Equipment 3Health News:Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM) 2Health News:Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM) 3Health News:Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM) 4
(Date:3/2/2015)... Ill. , March 2, 2015  Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... announced it will release financial results for the fiscal ... March 9, 2015. The Company will ... March 10, 2015 at 9:00 a.m. Central Time (10:00 ...
(Date:3/2/2015)... , March 2, 2015  Actavis plc ... it has closed its concurrent offerings of 14,513,889 ... 5.500% Mandatory Convertible Preferred Shares, Series A, at ... a separate registered public offering.  The amounts sold ... Preferred Shares issued pursuant to the exercise in ...
(Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
Breaking Medicine Technology:Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 2Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 3Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 4Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 5Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 6Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 7Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan 8BC Technical Acquires Eclipse Systems 2
... WARSAW, Ind., Oct. 27, 2011 Zimmer Holdings, Inc. (NYSE ... ended September 30, 2011.  The Company reported third quarter net ... reported and 2.4% constant currency over the third quarter of ... reported and $1.04 adjusted, an increase of 8.3% adjusted over ...
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) today ... SAFC® ( www.safcglobal.com ), is introducing a novel CHOZN® ... cell line. Designed for use in the production of ... first commercially available glutamine synthetase (GS) knockout CHO cell ...
Cached Medicine Technology:Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 2Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 3Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 4Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 5Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 6Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 7Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 8Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 9Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 10Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 11Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 12SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 2SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 3SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 4
... advanced multi-functional microplate detection system, ,offers ... without compromising flexibility. ,The Ultra ... the Ultra instrument platform. New features ... to the flexibility of the existing ...
... a fully automated microplate based multi-detection ... principles:, , Fluorescence Polarization , ... , High-Performance Luminescence (flash and glow) ... is designed for the widest possible ...
... a flexible multifunction plate reader that offers ... fluorescence intensity, time-resolved fluorescence, high-perfomance luminescence and ... with injectors that deliver reagent at the ... cell assays can be performed easily and ...
... High sensitivity and fast ... eight different radiometric and ... system with true high ... assays, by exploiting the ...
Medicine Products: